Skip to main content
. 2015 Feb 2;50(4):476–482. doi: 10.1038/bmt.2014.312

Figure 1.

Figure 1

Relative proportions of indications for an HSCT in Europe in 2013. (a) Proportions of disease indications for an allogeneic HSCT in Europe in 2013. (b) Proportions of disease indications for an autologous HSCT in Europe in 2013.